Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

Z Siergiejko, E Świebocka, N Smith… - … medical research and …, 2011 - Taylor & Francis
Background: Long-term oral corticosteroid (OCS) therapy and related adverse events are
associated with a significant burden on patients and healthcare resources. Methods: This …
被引用次数：75 相关文章

[引用][C] Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

Z Siergiejko, E Świebocka, N Smith, C Peckitt… - … Medical Research and …, 2011 - cir.nii.ac.jp

Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients.

Z Siergiejko, E Świebocka, N Smith… - Current Medical …, 2011 - europepmc.org
Background Long-term oral corticosteroid (OCS) therapy and related adverse events are
associated with a significant burden on patients and healthcare resources. Methods This …

Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients

Z Siergiejko, E Świebocka, N Smith, C Peckitt, J Leo… - 2011 - pubmed.ncbi.nlm.nih.gov
Background Long-term oral corticosteroid (OCS) therapy and related adverse events are
associated with a significant burden on patients and healthcare resources. Methods This …